BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schieda N, Blaichman JI, Costa AF, Glikstein R, Hurrell C, James M, Jabehdar Maralani P, Shabana W, Tang A, Tsampalieros A, van der Pol C, Hiremath S. Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2018;69:136-50. [PMID: 29706252 DOI: 10.1016/j.carj.2017.11.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Gopireddy DR, Mahmoud H, Baig S, Le R, Bhosale P, Lall C. "Renal emergencies: a comprehensive pictorial review with MR imaging". Emerg Radiol 2021;28:373-88. [PMID: 32974867 DOI: 10.1007/s10140-020-01852-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Apelt K, Bijkerk R, Lebrin F, Rabelink TJ. Imaging the Renal Microcirculation in Cell Therapy. Cells 2021;10:1087. [PMID: 34063200 DOI: 10.3390/cells10051087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 2021;77:517-28. [PMID: 32861792 DOI: 10.1053/j.ajkd.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Alabousi M, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training. Radiology 2021;300:279-84. [PMID: 34060939 DOI: 10.1148/radiol.2021210044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kamali M, Clarke SE, Costa AF. Evaluation of liver MRI examinations with two dosages of gadobenate dimeglumine: a blinded intra-individual study. Abdom Radiol (NY) 2020;45:36-44. [PMID: 31372778 DOI: 10.1007/s00261-019-02158-1] [Reference Citation Analysis]
6 Nikolaidou C, Karamitsos T. Should everyone have an MRI in heart failure? Cardiovasc Diagn Ther 2020;10:549-53. [PMID: 32695635 DOI: 10.21037/cdt.2019.12.06] [Reference Citation Analysis]
7 Schieda N, van der Pol CB, Walker D, Tsampalieros AK, Maralani PJ, Woo S, Davenport MS. Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis. Radiology 2020;297:565-72. [DOI: 10.1148/radiol.2020200073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
8 Steubl D, Inker LA. How best to estimate glomerular filtration rate? Novel filtration markers and their application. Curr Opin Nephrol Hypertens 2018;27:398-405. [PMID: 30063487 DOI: 10.1097/MNH.0000000000000444] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
9 Liu H, Liu H, Yang Z, Wang K. Bone Mineral Density in Population Long-Term Exposed to Rare Earth Elements from a Mining Area of China. Biol Trace Elem Res 2021;199:453-64. [PMID: 32361884 DOI: 10.1007/s12011-020-02165-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Gauthier ID, Macleod CA, Sathiadoss P, Mcgrath TA, Nair V, Schieda N. Risk of nephrogenic systemic fibrosis (NSF) in oncology patients receiving gadoxetic acid and updated risk of estimate of NSF in patients receiving gadoxetic acid with moderate and severe renal impairment. Abdom Radiol. [DOI: 10.1007/s00261-021-03367-3] [Reference Citation Analysis]
11 Jabehdar Maralani P, Kapadia A, Liu G, Moretti F, Ghandehari H, Clarke SE, Wiebe S, Garel J, Ertl-Wagner B, Hurrell C, Schieda N. Canadian Association of Radiologists Recommendations for the Safe Use of MRI During Pregnancy. Can Assoc Radiol J 2021;:8465371211015657. [PMID: 34000852 DOI: 10.1177/08465371211015657] [Reference Citation Analysis]
12 Varjú C, Kumánovics G, Czirják L, Matucci-Cerinic M, Minier T. Sclerodermalike syndromes: Great imitators. Clin Dermatol 2020;38:235-49. [PMID: 32513403 DOI: 10.1016/j.clindermatol.2019.10.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Thurman J, Gueler F. Recent advances in renal imaging. F1000Res 2018;7:F1000 Faculty Rev-1867. [PMID: 30631428 DOI: 10.12688/f1000research.16188.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
14 van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. Developments in the treatment of Fabry disease. J Inherit Metab Dis 2020;43:908-21. [PMID: 32083331 DOI: 10.1002/jimd.12228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
15 Poli FE, Gulsin GS, McCann GP, Burton JO, Graham-Brown MP. The assessment of coronary artery disease in patients with end-stage renal disease. Clin Kidney J 2019;12:721-34. [PMID: 31583096 DOI: 10.1093/ckj/sfz088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Baroni RH, Bauab T Jr, Bittencourt LK, D'Ippolito G, Goldman SM, Hohgraefe Neto G, Manzella A, Rocha AJ, Sonoda LA, Takeda FS. Practical recommendations for the safe use of gadolinium in magnetic resonance imaging: a Delphi expert panel study. Radiol Bras 2020;53:216-22. [PMID: 32904664 DOI: 10.1590/0100-3984.2019.0074] [Reference Citation Analysis]
17 Timms L, Zhou T, Lyu Y, Qiao J, Mishra V, Lahoud RM, Jayaraman GV, Allegretti AS, Drew D, Seethamraju RT, Harisinghani M, Sridhar S. Ferumoxytol-enhanced ultrashort TE MRA and quantitative morphometry of the human kidney vasculature. Abdom Radiol (NY) 2021;46:3288-300. [PMID: 33666735 DOI: 10.1007/s00261-021-02984-2] [Reference Citation Analysis]
18 Farrow JM, Kern SQ, Gryzinski GM, Sundaram CP. Nephron-sparing management of upper tract urothelial carcinoma. Investig Clin Urol 2021;62:389-98. [PMID: 34190434 DOI: 10.4111/icu.20210113] [Reference Citation Analysis]
19 Vasquez M, Nagel E. Clinical indications for cardiovascular magnetic resonance. Heart 2019;105:1755-62. [PMID: 31666349 DOI: 10.1136/heartjnl-2018-312971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Nery F, Buchanan CE, Harteveld AA, Odudu A, Bane O, Cox EF, Derlin K, Gach HM, Golay X, Gutberlet M, Laustsen C, Ljimani A, Madhuranthakam AJ, Pedrosa I, Prasad PV, Robson PM, Sharma K, Sourbron S, Taso M, Thomas DL, Wang DJJ, Zhang JL, Alsop DC, Fain SB, Francis ST, Fernández-Seara MA. Consensus-based technical recommendations for clinical translation of renal ASL MRI. MAGMA 2020;33:141-61. [PMID: 31833014 DOI: 10.1007/s10334-019-00800-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
21 Krestan C. [Contrast media - Guidelines for practical use]. Radiologe 2019;59:444-53. [PMID: 31025046 DOI: 10.1007/s00117-019-0523-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Tammaro O, Costagliola di Polidoro A, Romano E, Netti PA, Torino E. A Microfluidic Platform to design Multimodal PEG - crosslinked Hyaluronic Acid Nanoparticles (PEG-cHANPs) for diagnostic applications. Sci Rep 2020;10:6028. [PMID: 32265496 DOI: 10.1038/s41598-020-63234-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Rouvière O, Cornelis F, Brunelle S, Roy C, André M, Bellin MF, Boulay I, Eiss D, Girouin N, Grenier N, Hélénon O, Lapray JF, Lefèvre A, Matillon X, Ménager JM, Millet I, Ronze S, Sanzalone T, Tourniaire J, Rocher L, Renard-Penna R; “French Society of Genitourinary Imaging Consensus group”. Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging. Eur Radiol 2020;30:2103-14. [PMID: 31900706 DOI: 10.1007/s00330-019-06530-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Chehabeddine L, Al Saleh T, Baalbaki M, Saleh E, Khoury SJ, Hannoun S. Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents. Critical Reviews in Toxicology 2019;49:262-79. [DOI: 10.1080/10408444.2019.1592109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
25 Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2019;70:226-32. [DOI: 10.1016/j.carj.2019.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
26 Lin BS, Chen CW, Zhou SK, Tseng YH, Wang SC, Huang YK. Evaluation of static ulcer on lower extremities using wireless wearable near-infrared spectroscopy device: Effect of deep venous thrombosis on TRiggered Angiography Non-Contrast-Enhanced sequence magnetic resonance imaging. Phlebology 2020;35:814-23. [PMID: 32700650 DOI: 10.1177/0268355520935739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Srivastava A, Tomar B, Prajapati S, Gaikwad AB, Mulay SR. Advanced non-invasive diagnostic techniques for visualization and estimation of kidney fibrosis. Drug Discov Today 2021;26:2053-63. [PMID: 33617976 DOI: 10.1016/j.drudis.2021.02.016] [Reference Citation Analysis]
28 Viteri B, Calle-Toro JS, Ballester L, Darge K, Furth S, Khrichenko D, Van Batavia J, Otero H. Potential benefits of functional magnetic resonance urography (fMRU) over MAG3 renal scan in children with obstructive uropathy. J Pediatr Urol 2021;17:659.e1-7. [PMID: 34426090 DOI: 10.1016/j.jpurol.2021.07.005] [Reference Citation Analysis]
29 Walker DT, Davenport MS, McGrath TA, McInnes MDF, Shankar T, Schieda N. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis. Radiology 2020;296:312-21. [PMID: 32427558 DOI: 10.1148/radiol.2020192855] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
30 Chen K, Li P, Zhu C, Xia Z, Xia Q, Zhong L, Xiao B, Cheng T, Wu C, Shen C, Zhang X, Zhu J. Mn(II) Complex of Lipophilic Group-Modified Ethylenediaminetetraacetic Acid (EDTA) as a New Hepatobiliary MRI Contrast Agent. J Med Chem 2021;64:9182-92. [PMID: 34152137 DOI: 10.1021/acs.jmedchem.1c00393] [Reference Citation Analysis]